Sarepta Therapeutics Inc (NAS:SRPT)
$ 121.5 -1.87 (-1.52%) Market Cap: 11.61 Bil Enterprise Value: 11.98 Bil PE Ratio: 78.90 PB Ratio: 9.50 GF Score: 86/100

Q2 2020 Sarepta Therapeutics Inc Earnings Call Transcript

Aug 05, 2020 / 08:30PM GMT
Release Date Price: $158.89 (+1.38%)
Operator

Good day, ladies and gentlemen, and welcome to the Sarepta Therapeutics Second Quarter 2020 Earnings Call. (Operator Instructions) As a reminder, todayâs program is being recorded. At this time, Iâll turn the call over to Mary Jenkins, Manager, Investor Relations. Please go ahead.

Mary Jenkins;Manager
Investor Relations,

Thank you, operator, and thank you all for joining todayâs call. Earlier today, we released our financial results for the second quarter 2020. The press release is available on our website at sarepta.com and our 10-Q was filed with the SEC earlier this afternoon. Joining us on the call today are Doug Ingram, Bill Ciambrone, Ian Estepan, Dr. Gilmore OâNeill and Dr. Louise Rodino-Klapac. After our formal remarks, weâll open the call for Q&A.

Iâd like to note that during this call, we will be making a number of forward-looking statements. Please take a moment to review our slide on the webcast which contains our forward-looking statements. These forward-looking statements involve risks and uncertainties many of which

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot